Emergent BioSolutions | Stammkapital



Ordinary Share Capital Veränderung Datum
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
ALKERMES USD 165.05M 163.25M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amarin USD 308.15M 2.85M 2025-03
ANI Pharmaceuticals USD 2K 0 2025-03
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Exact Sciences USD 189.22M 187.33M 2025-06
Exelixis USD 270.13M 269.86M 2025-07
Glaxosmithkline GBP 4.15B 2.8B 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
Ironwood Pharmaceuticals USD 160K 0 2024-12
Lonza CHF 72M 0 2024-12
Merck USD 1.79B 0 2025-03
Moderna USD 389M 388.96M 2025-06
Myriad Genetics USD 900K 0 2025-03
Neurocrine Biosciences USD 99M 0 2025-06
Pacira USD 44.9M 44.85M 2025-06
Pfizer USD 5.68B 5.2B 2025-06
PTC Therapeutics USD 79.38M 79.3M 2025-06
Sanofi 1.22B 36.5M 2025-06
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
United Therapeutics USD 45.22M 44.42M 2025-06


Emergent BioSolutions Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.